Trump, Jeffrey Epstein
Digest more
President Donald Trump is losing the support of suburban Americans, polling reveals. According to polling by Quantus Insights, the proportion of people from the suburbs who approve of the president has declined from -3 percentage points in September to -16 points in December.
The new Reuters/Ipsos poll, released Thursday, showed that Republicans hold an edge over Democrats among older voters.
President Donald Trump’s aggressive policy agenda is doing more than reshaping the economy and immigration enforcement - it’s also giving a handful of Democratic governors a national stage to position themselves as potential 2028 presidential contenders.
An investigation by The Times found the administration’s change in enforcement benefited the industry, including companies that had ties to the president.
The video shows Donald Trump, 79, and Melania, 55, arm in arm, carefully descending a staircase in the grand foyer of the White House to the tune of “Hail to the Chief.” But the FLOTUS-approved video appears to be slightly slowed down from other footage of the Trumps coming down the stairs on the night at a marginally faster pace.
President Donald Trump has been dealt another polling blow ahead of Christmas. A new survey from the Associated Press-NORC Center for Public Affairs Research found that rising financial strain is causing Americans to cut back on non-essential spending and put off big-ticket item purchases ahead of the holiday season.
The White House plans to make affordability a key selling point for Republicans across the board as the 2026 midterm elections come into focus.
1don MSN
Trump cuts family reunification programs for seven countries citing fraud and security concerns
Trump administration ends family reunification parole programs for immigrants from Colombia, Cuba, Ecuador, El Salvador, Guatemala, Haiti, and Honduras.
"Around the world, America stands for something. Or it did," Jeremiah Johnson, a Trump-appointed judge, told Newsweek.
Marijuana currently is classified as a Schedule I drug, which the DEA describes as a substance with no "medical use and a high potential for abuse."